Drug Shortage Report for TEVA-DICLOFENAC EC

Last updated on 2020-07-10 History
Report ID 99453
Drug Identification Number 00808539
Brand name TEVA-DICLOFENAC EC
Common or Proper name DICLOFENAC 25MG TABLETS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DICLOFENAC SODIUM
Strength(s) 25MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-08-01
Actual start date
Estimated end date
Actual end date 2020-06-29
Shortage status Avoided shortage
Updated date 2020-07-10
Company comments Will be allocating to cover our market until resupply in Aug 2020
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-07-10 French Compare
v10 2020-07-10 English Compare
v9 2019-12-05 French Compare
v8 2019-12-05 English Compare
v7 2019-12-05 French Compare
v6 2019-12-05 English Compare
v5 2019-11-28 French Compare
v4 2019-11-28 English Compare
v3 2019-11-22 English Compare
v2 2019-11-21 French Compare
v1 2019-11-21 English Compare

Showing 1 to 11 of 11